Evidence map›Paper›PMID 27572622›Full record

ReviewEMBO molecular medicine2016

Immunoregulatory functions of immune complexes in vaccine and therapy.

Yu-Mei Wen, Libing Mu, Yan Shi

Open access · goldAbstract readReview
In one paragraph

Review in EMBO molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.Current topics in microbiology and immunology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Yu-Mei WenKey Laboratory of Molecular Medical Virology, MOE/MOH, School of Basic Medical Sciences Shanghai Medical College Fudan University, Shanghai, China ymwen@shmu.edu.cn yanshi@biomed.tsinghua.edu.cn.
Libing MuCenter for Life Sciences, Department of Basic Medical Sciences, Institute of Immunology Tsinghua University, Beijing, China.
Yan ShiCenter for Life Sciences, Department of Basic Medical Sciences, Institute of Immunology Tsinghua University, Beijing, China Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada ymwen@shmu.edu.cn yanshi@biomed.tsinghua.edu.cn.ORCID 0000-0002-6715-7681
Center for Life Sciences · CNShanghai Medical College of Fudan University · CNUniversity of Calgary · CA

Funding

Adjuvants' mechanismsR01AI098995 · NIAID · UNIVERSITY OF CALGARY · PI SHI, YAN · 2012 to 2016
$1.0M
CIHR MOP‐119295NIAID NIH HHS R01 AI098995
6 · The paper itself

Abstract

Clinical and experimental preparations of IgG/soluble antigen complexes, as well as those formed following antibody therapy in vivo, are multifaceted immune regulators. These immune complexes (ICs) have been tested in humans and animal models, mostly in forms of experimental or clinical vaccination, for at least a century. With intensified research on Fcγ receptor-mediated immune modulation, as well as with immune complex-directed antigen processing, presentation, and inflammatory responses, there are renewed interests of using ICs in vaccines and immunotherapies. Currently, IC-based immune therapy has been broadly experimented in HBV and HIV viral infection control and antitumor treatments. However, mechanistic insights of IC-based treatments are relatively recent subjects of study; strong efforts are needed to establish links to connect laboratory findings with clinical practices. This review covers the history, mechanisms, and in vivo outcomes of this safe and effective therapeutic tool, with a clear aim to bridge laboratory findings with evolving clinical applications.

Indexed as

AnimalsAntigen-Antibody ComplexDisease Models, AnimalDrug Evaluation, PreclinicalHepatitis B, ChronicHIV InfectionsHumansImmunologic FactorsImmunotherapyNeoplasmsAntigen-Antibody ComplexImmunologic FactorsadjuvantFcγRimmune compleximmune therapyvaccine

Identifiers

PMID27572622
PMCPMC5048363
OpenAlexW2511521044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.